Viora

Company Overview

Snapshot

Founded in August 2005, Viora is a medical aesthetics company with 51–200 employees. The company was acquired by Sinclair Pharma in February 2022, marking a significant exit in the medical aesthetics market.

Business overview

Viora develops non-invasive and minimally invasive products for a wide range of aesthetic procedures. Its core technology addresses skin tightening, body and facial contouring, cellulite reduction, skin rejuvenation, acne treatment, skin resurfacing, stretch mark reduction, hair removal, and skin lightening. Operating within the Health Tech & Life Sciences sector, specifically Medical Devices and Medical Treatment & Therapeutics, Viora serves clinics and healthcare providers globally.

Strategic signal

In February 2022, Viora was acquired by Sinclair Pharma, integrating its energy-based devices into Sinclair Pharma's portfolio. This acquisition signals a strategic consolidation within the medical aesthetics industry, allowing Sinclair Pharma to expand its product offerings and market reach with Viora's established non-invasive and minimally invasive solutions.

Company Intelligence Q&A

When was Viora acquired?

Viora was acquired by Sinclair Pharma in February 2022.

What was a key product launch for Viora in 2020?

In March 2020, Viora revolutionized laser hair removal with the introduction of its new DioBreeze™ system.

What was Viora's financial performance in 2017?

Viora concluded 2017 with record profitability and growth, as reported in March 2018.

What significant acquisition did Viora make in 2021?

In August 2021, Viora successfully acquired the EnerJet & AirJet Systems, expanding its product portfolio.